BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15681900)

  • 1. A novel variant allele of OATP-C (SLCO1B1) found in a Japanese patient with pravastatin-induced myopathy.
    Morimoto K; Oishi T; Ueda S; Ueda M; Hosokawa M; Chiba K
    Drug Metab Pharmacokinet; 2004 Dec; 19(6):453-5. PubMed ID: 15681900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1).
    Niemi M; Schaeffeler E; Lang T; Fromm MF; Neuvonen M; Kyrklund C; Backman JT; Kerb R; Schwab M; Neuvonen PJ; Eichelbaum M; Kivistö KT
    Pharmacogenetics; 2004 Jul; 14(7):429-40. PubMed ID: 15226675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional analysis of a mutation in the SLCO1B1 gene (c.1628T>G) identified in a Japanese patient with pravastatin-induced myopathy.
    Furihata T; Satoh N; Ohishi T; Ugajin M; Kameyama Y; Morimoto K; Matsumoto S; Yamashita K; Kobayashi K; Chiba K
    Pharmacogenomics J; 2009 Jun; 9(3):185-93. PubMed ID: 19238167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: consequences for pravastatin pharmacokinetics.
    Nishizato Y; Ieiri I; Suzuki H; Kimura M; Kawabata K; Hirota T; Takane H; Irie S; Kusuhara H; Urasaki Y; Urae A; Higuchi S; Otsubo K; Sugiyama Y
    Clin Pharmacol Ther; 2003 Jun; 73(6):554-65. PubMed ID: 12811365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional characterization of SLCO1B1 (OATP-C) variants, SLCO1B1*5, SLCO1B1*15 and SLCO1B1*15+C1007G, by using transient expression systems of HeLa and HEK293 cells.
    Kameyama Y; Yamashita K; Kobayashi K; Hosokawa M; Chiba K
    Pharmacogenet Genomics; 2005 Jul; 15(7):513-22. PubMed ID: 15970799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional characterization for polymorphic organic anion transporting polypeptides (OATP/SLCO1B1, 1B3, 2B1) of monkeys recombinantly expressed with various OATP probes.
    Takahashi T; Uno Y; Yamazaki H; Kume T
    Biopharm Drug Dispos; 2019 Feb; 40(2):62-69. PubMed ID: 30652318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphisms of human organic anion transporters OATP-C (SLC21A6) and OATP-B (SLC21A9): allele frequencies in the Japanese population and functional analysis.
    Nozawa T; Nakajima M; Tamai I; Noda K; Nezu J; Sai Y; Tsuji A; Yokoi T
    J Pharmacol Exp Ther; 2002 Aug; 302(2):804-13. PubMed ID: 12130747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of genetic polymorphism of OATP-C (SLCO1B1) on lipid-lowering response to HMG-CoA reductase inhibitors.
    Tachibana-Iimori R; Tabara Y; Kusuhara H; Kohara K; Kawamoto R; Nakura J; Tokunaga K; Kondo I; Sugiyama Y; Miki T
    Drug Metab Pharmacokinet; 2004 Oct; 19(5):375-80. PubMed ID: 15548849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of SLCO1B1 and ABCB1 Genetic Variants with Atorvastatin-induced Myopathy in Patients with Acute Ischemic Stroke.
    Zhang L; Lv H; Zhang Q; Wang D; Kang X; Zhang G; Li X
    Curr Pharm Des; 2019; 25(14):1663-1670. PubMed ID: 31298164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional characterization of human organic anion transporting polypeptide B (OATP-B) in comparison with liver-specific OATP-C.
    Tamai I; Nozawa T; Koshida M; Nezu J; Sai Y; Tsuji A
    Pharm Res; 2001 Sep; 18(9):1262-9. PubMed ID: 11683238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [OATP 1B1 T521C/A388G is an important polymorphism gene related to neonatal hyperbilirubinemia].
    Zhang HX; Zhao X; Yang Z; Peng CY; Long R; Li GN; Li J; He ZK
    Zhonghua Er Ke Za Zhi; 2010 Sep; 48(9):650-5. PubMed ID: 21092521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for inverse effects of OATP-C (SLC21A6) 5 and 1b haplotypes on pravastatin kinetics.
    Mwinyi J; Johne A; Bauer S; Roots I; Gerloff T
    Clin Pharmacol Ther; 2004 May; 75(5):415-21. PubMed ID: 15116054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid identification of three functionally relevant polymorphisms in the OATP1B1 transporter gene using Pyrosequencing.
    Rohrbacher M; Kirchhof A; Skarke C; Geisslinger G; Lötsch J
    Pharmacogenomics; 2006 Mar; 7(2):167-76. PubMed ID: 16515396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Uremic Serum Residue on OATP1B1- and OATP1B3-Mediated Pravastatin Uptake in OATP-Expressing HEK293 Cells and Human Hepatocytes.
    Uchiyama H; Tsujimoto M; Kimura A; Yuki E; Saiki T; Yoshida T; Furukubo T; Izumi S; Yamakawa T; Tachiki H; Minegaki T; Nishiguchi K
    Ther Apher Dial; 2019 Apr; 23(2):126-132. PubMed ID: 30318712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between SLCO1B1 T521C polymorphism and risk of statin-induced myopathy: a meta-analysis.
    Xiang Q; Chen SQ; Ma LY; Hu K; Zhang Z; Mu GY; Xie QF; Zhang XD; Cui YM
    Pharmacogenomics J; 2018 Dec; 18(6):721-729. PubMed ID: 30250148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of OATP transporter-mediated drug-drug interaction using physiologically-based pharmacokinetic (PBPK) modeling - a case example.
    Chen Y; Zhu R; Ma F; Mao J; Chen EC; Choo EF; Sahasranaman S; Liu L
    Biopharm Drug Dispos; 2018 Nov; 39(9):420-430. PubMed ID: 30335192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic myopathies discovered during investigations of statin myopathy.
    Baker SK; Vladutiu GD; Peltier WL; Isackson PJ; Tarnopolsky MA
    Can J Neurol Sci; 2008 Mar; 35(1):94-7. PubMed ID: 18380285
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of inhalation exposure to toluene on the activity of organic anion transporting polypeptide (Oatp) using pravastatin as a probe drug in rats.
    Mauro M; Lepera JS; Borsari B; Capela JMV; de Moraes NV
    Xenobiotica; 2018 Jul; 48(7):734-738. PubMed ID: 28686078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel single nucleotide polymorphism of UGT1A9 gene in Japanese.
    Fujita K; Ando Y; Nagashima F; Yamamoto W; Endo H; Kodama K; Araki K; Miya T; Narabayashi M; Sasaki Y
    Drug Metab Pharmacokinet; 2006 Feb; 21(1):79-81. PubMed ID: 16547398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel RNA splicing mutation in Japanese patients with Wilson disease.
    Shimizu N; Kawase C; Nakazono H; Hemmi H; Shimatake H; Aoki T
    Biochem Biophys Res Commun; 1995 Dec; 217(1):16-20. PubMed ID: 8526905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.